Long-term humoral response following Delta and Omicron BA.1 co-infection

Long-term humoral response following Delta and Omicron BA.1 co-infection

Abstract This study reports the 6-month humoral immune response in vaccinated patients concomitantly infected with Delta and Omicron BA.1 variants of SARS-CoV-2. Interestingly, the simultaneous exposure to the Delta and BA.1 S proteins does not confer an additional immune advantage compared to expos...

Full description

Bibliographic Details
Main Authors:	Carla Saade, Bruno Pozzetto, Melyssa Yaugel-Novoa, Guy Oriol, Laurence Josset, Bruno Lina, Stéphane Paul, Antonin Bal, Sophie Trouillet-Assant
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-04-01
Series:	npj Vaccines
Online Access:	https://doi.org/10.1038/s41541-023-00652-8

Similar Items

Dynamics of viral shedding during ancestral or Omicron BA.1 SARS-CoV-2 infection and enhancement of pre-existing immunity during breakthrough infections
by: Carla Saade, et al.
Published: (2022-12-01)

Metagenomic Investigation of Torque Teno Mini Virus-SH in Hematological Patients
by: Antonin Bal, et al.
Published: (2019-09-01)

SARS-CoV-2 Omicron Variant, Lineage BA.1, Is Associated with Lower Viral Load in Nasopharyngeal Samples Compared to Delta Variant
by: Célia Sentis, et al.
Published: (2022-04-01)

Characterization of SARS-CoV-2 ORF6 deletion variants detected in a nosocomial cluster during routine genomic surveillance, Lyon, France
by: Grégory Quéromès, et al.
Published: (2021-01-01)

Metagenomic Next-Generation Sequencing Reveals Individual Composition and Dynamics of Anelloviruses during Autologous Stem Cell Transplant Recipient Management
by: Antonin Bal, et al.
Published: (2018-11-01)

A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects.
by: Jasper de Boer, et al.
Published: (2022-01-01)

A novel assessment method for COVID-19 humoral immunity duration using serial measurements in naturally infected and vaccinated subjects
by: Jasper de Boer, et al.
Published: (2022-01-01)

Detection and prevalence of SARS-CoV-2 co-infections during the Omicron variant circulation in France
by: Antonin Bal, et al.
Published: (2022-10-01)

Systematic SARS-CoV-2 screening in cerebrospinal fluid during the COVID-19 pandemic
by: Grégory Destras, et al.
Published: (2020-08-01)

Comparison of Neutralizing Activity between Vaccinated and Unvaccinated Hospitalized COVID-19 Patients Infected with Delta, Omicron BA.1, or Omicron BA.2 Variant
by: Keun Ju Kim, et al.
Published: (2024-03-01)

A booster of Delta-Omicron RBD-dimer protein subunit vaccine augments sera neutralization of Omicron sub-variants BA.1/BA.2/BA.2.12.1/BA.4/BA.5
by: Minrun Duan, et al.
Published: (2023-12-01)

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
by: Annika Rössler, et al.
Published: (2022-12-01)

Immune responses in COVID-19 patients during breakthrough infection with SARS-CoV-2 variants Delta, Omicron-BA.1 and Omicron-BA.5
by: Maren Bormann, et al.
Published: (2023-07-01)

Understanding spatiotemporal symptom onset risk of Omicron BA.1, BA.2 and hamster-related Delta AY.127
by: Chengzhuo Tong, et al.
Published: (2022-09-01)

Estimating relative generation times and reproduction numbers of Omicron BA.1 and BA.2 with respect to Delta variant in Denmark
by: Kimihito Ito, et al.
Published: (2022-06-01)

Virological Characteristics of Five SARS-CoV-2 Variants, Including Beta, Delta and Omicron BA.1, BA.2, BA.5
by: Yan Zeng, et al.
Published: (2023-12-01)

Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa
by: Nicole Wolter, et al.
Published: (2022-10-01)

Structural Evolution of Delta (B.1.617.2) and Omicron (BA.1) Spike Glycoproteins
by: Ingrid Guarnetti Prandi, et al.
Published: (2022-08-01)

Humoral responses against SARS-CoV-2 Omicron BA.2.11, BA.2.12.1 and BA.2.13 from vaccine and BA.1 serum
by: Jiandong Huo, et al.
Published: (2022-11-01)

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion
by: Delphine Planas, et al.
Published: (2024-03-01)

Metagenomic Analysis Reveals High Abundance of Torque Teno Mini Virus in the Respiratory Tract of Children with Acute Respiratory Illness
by: Antonin Bal, et al.
Published: (2022-05-01)

Omicron BA.5 Neutralization among Vaccine-Boosted Persons with Prior Omicron BA.1/BA.2 Infections
by: Rune M. Pedersen, et al.
Published: (2022-12-01)

Impact of Dextran-Sodium-Sulfate-Induced Enteritis on Murine Cytomegalovirus Reactivation
by: Alexandre Jentzer, et al.
Published: (2022-11-01)

Comparative neutralization profiles of naive and breakthrough infections with Delta, Omicron BA.1 and BA.2 variants of SARS-CoV-2
by: Yang Yang, et al.
Published: (2022-09-01)

The SARS-CoV-2 Delta-Omicron Recombinant Lineage (XD) Exhibits Immune-Escape Properties Similar to the Omicron (BA.1) Variant
by: Prerna Arora, et al.
Published: (2022-11-01)

Vaccine- and Breakthrough Infection-Elicited Pre-Omicron Immunity More Effectively Neutralizes Omicron BA.1, BA.2, BA.4 and BA.5 Than Pre-Omicron Infection Alone
by: Eveline Santos da Silva, et al.
Published: (2023-02-01)

SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in Mice
by: Mariana Baz, et al.
Published: (2022-11-01)

Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
by: T. Selvavinayagam, Sivaprakasam, et al.
Published: (2022)

Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
by: Sivaprakasam T. Selvavinayagam, et al.
Published: (2022-09-01)

Riding the Omicron BA.5 Wave: Improved Humoral Response after Vaccination with Bivalent Omicron BA.4-5-Adapted mRNA SARS-CoV-2 Vaccine in Chronic Hemodialysis Patients
by: Eugen Ovcar, et al.
Published: (2023-08-01)

Omicron-BA.1 Dispersion Rates in Mexico Varied According to the Regional Epidemic Patterns and the Diversity of Local Delta Subvariants
by: Selene Zárate, et al.
Published: (2023-01-01)

Protection of COVID-19 vaccination and previous infection against Omicron BA.1, BA.2 and Delta SARS-CoV-2 infections
by: Stijn P. Andeweg, et al.
Published: (2022-08-01)

Omicron BA.2 to dominate in Malaysia
by: Teoh, Pei Ying
Published: (2022)

Simultaneous co-infection with Omicron (B.1.1.529) and Delta (21A/478K.V1) SARS-CoV-2 variants confirmed by whole genome sequencing
by: Souheil Zayet, et al.
Published: (2022-11-01)

Fatal cases after Omicron BA.1 and BA.2 infection: Results of an autopsy study
by: Bruno Märkl, et al.
Published: (2023-03-01)

Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance
by: Rajkumar Chinnadurai, et al.
Published: (2022-03-01)

Clinical and humoral immune response characterization of SARS-CoV-2 Omicron BA.2.38 infection in pediatric patients
by: Yu Liu, et al.
Published: (2023-07-01)

Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA.5 variants following vaccination in myelofibrosis patients
by: Ahmad Alcheikh, et al.
Published: (2023-04-01)

Antiviral Activities of HIV-1-Specific Human Broadly Neutralizing Antibodies Are Isotype-Dependent
by: Blandine Noailly, et al.
Published: (2022-06-01)

Immune Functional Assays, From Custom to Standardized Tests for Precision Medicine
by: Chloé Albert-Vega, et al.
Published: (2018-10-01)